S Z 228 (Zolpidem tartrate extended release 6.25 mg)
Pill imprint S Z 228 has been identified as Zolpidem tartrate extended release 6.25 mg.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- S Z 228
- Strength:
- 6.25 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Sandoz Inc
- National Drug Code (NDC):
- 00781-5315
- Inactive Ingredients:
- silicon dioxide
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
ferric oxide red
magnesium silicate
titanium dioxide
More about zolpidem
Consumer resources
- Zolpidem
- Zolpidem extended-release tablets
- Zolpidem spray
- Zolpidem (Advanced Reading)
- Zolpidem Oral, Oromucosal (Advanced Reading)
- Other brands: Ambien, Ambien CR, Intermezzo, Zolpimist, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
